Department of Internal Medicine, Faculty of Medicine, Notre-Dame du Kasayi University, Kananga, Congo.
Department of Internal Medicine, Center Hospitalier Mère-Enfant Monkole, Kinshasa, Congo.
BMC Cardiovasc Disord. 2023 Sep 4;23(1):439. doi: 10.1186/s12872-023-03467-6.
Pulmonary embolism is a frequent cause of intra-hospital mortality. The survival of patients depends not only on the speed of diagnosis but also on the treatment initiated.
to evaluate the intra-hospital survival of patients with pulmonary embolism in the city of Kinshasa.
analytical cross-sectional study based on non-probability convenience sampling carried out in the city of Kinshasa; three hospitals selected for convenience on the basis of their technical platforms. The patients were judged to have had a pulmonary embolism after a chest CT angiography proved it. The data recorded on the Kobocollect site were exported in Excel format and analyzed with SPSS software version 23. The comparison of the means was made using the Student test and that frequencies with the Yates Chi-square test. The association was attributed by the calculation of the odds ratio and the survival presented according to the Cox regression.
Eighty-nine cases or 63 women and 26 men were analyzed, the mean age was 64.4 ± 15.6 years. Individuals over 65 died more (ß=0.043 and p-Value of 0.01) the female sex multiplied by 1.38 the risk of death (DNS, p-Value = 0.478). Approximately 80% of patients were classified as PESI stage II or III. Starting Rivaroxaban from the outset does not show any difference with enoxaparin in terms of intra-hospital survival.
Pulmonary embolism is a real problem in our environment, the age of more than 65 years and the female sex are factors of poor prognosis and predicted survival.
肺栓塞是院内死亡的常见原因。患者的存活率不仅取决于诊断的速度,还取决于所启动的治疗。
评估金沙萨市肺栓塞患者的院内存活率。
这是一项基于非概率便利性抽样的分析性横断面研究,在金沙萨市进行;基于技术平台的便利性选择了三家医院。通过胸部 CT 血管造影证实患者患有肺栓塞后进行判断。在 Kobocollect 网站上记录的数据以 Excel 格式导出,并使用 SPSS 软件版本 23 进行分析。平均值的比较采用学生检验,频率的比较采用 Yates 卡方检验。通过计算比值比和根据 Cox 回归呈现生存情况来确定关联。
共分析了 89 例病例,其中 63 例为女性,26 例为男性,平均年龄为 64.4±15.6 岁。65 岁以上的个体死亡风险更高(ß=0.043,p 值为 0.01),女性的死亡风险增加 1.38 倍(DNS,p 值=0.478)。大约 80%的患者被归类为 PESI Ⅱ期或Ⅲ期。从一开始就使用利伐沙班与使用依诺肝素相比,在院内存活率方面没有差异。
肺栓塞在我们的环境中是一个真实存在的问题,65 岁以上的年龄和女性是预后不良和预测生存的因素。